✦ LIBER ✦

Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer

✍ Scribed by Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lippe, Paolo; Trivisonne, Raffaele; Buzzi, Franco; De Signoribus, Giorgio; Tuveri, Guido; Rossi, Giorgio; Di Lullo, Liberato; Sturba, Fabio; Morale, Donatella; Catanzani, Sergio; Pilone, Alberta; Bonsignori, Maurizio; Battelli, Tullio

Book ID: 118571118
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 216 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)00140-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of gemcitabine plus cispl

Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer

✍ Yu, Hai-feng; Wu, Feng-qin; Fan, Yun; Lin, Neng-ming; Ma, Sheng-lin; Luo, Lü-hon 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 Chinese ⚖ 317 KB

O-220 Gemcitabine plus cisplatin versus

O-220 Gemcitabine plus cisplatin versus gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: A phase III randomized trial

✍ Zatloukal, Petr; Petruzelka, Lubos; Zemanova, Milada; Kolek, Vitezslav; Skrickov 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Gemcitabine plus cisplatin vs. gemcitabi

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

✍ Zatloukal, Petr; Petruželka, Luboš; Zemanová, Milada; Kolek, Vı́tězslav; Skřičko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Gemcitabine-cisplatin (GP) vs gemcitabin

Gemcitabine-cisplatin (GP) vs gemcitabine-carboplatin (GC) in advanced non-small cell lung cancer (NSCLC): a multicenter phase II randomized trial

✍ P. Mazzanti; C. Massacesi; R. Mattioli; R. Trivisonne; F. Buzzi; G. De Signoribu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Docetaxel plus cisplatin versus docetaxe

Docetaxel plus cisplatin versus docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trial

✍ V. Georgoulias; E. Papadakis; A. Alexopoulos; E. Stavrinidis; E. Bania; A. Rapti 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Randomized multicentric phase II study o

Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer

✍ Thomas, P.; Robinet, G.; Gouva, S.; Fournel, P.; Léna, H.; Le Caer, H.; Perol, M 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 204 KB